Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer.

Merkow RP, Bentrem DJ, Mulcahy MF, Chung JW, Abbott DE, Kmiecik TE, Stewart AK, Winchester DP, Ko CY, Bilimoria KY.

Ann Surg. 2013 Dec;258(6):847-53. doi: 10.1097/SLA.0000000000000312.

PMID:
24169157
2.

Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.

Merkow RP, Bilimoria KY, Tomlinson JS, Paruch JL, Fleming JB, Talamonti MS, Ko CY, Bentrem DJ.

Ann Surg. 2014 Aug;260(2):372-7. doi: 10.1097/SLA.0000000000000378.

PMID:
24374509
3.

Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.

van der Geest LG, Portielje JE, Wouters MW, Weijl NI, Tanis BC, Tollenaar RA, Struikmans H, Nortier JW; All Nine Hospitals in the Leiden Region of the Comprehensive Cancer Centre The Netherlands.

Colorectal Dis. 2013;15(10):e582-91. doi: 10.1111/codi.12288.

PMID:
23679338
4.

Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.

Becerra AZ, Probst CP, Tejani MA, Aquina CT, González MG, Hensley BJ, Noyes K, Monson JR, Fleming FJ.

Surgery. 2015 Sep;158(3):692-9. doi: 10.1016/j.surg.2015.03.057. Epub 2015 May 29.

PMID:
26032822
5.

Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Schrag D, Cramer LD, Bach PB, Begg CB.

J Natl Cancer Inst. 2001 Jun 6;93(11):850-7.

6.

Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.

Winget M, Hossain S, Yasui Y, Scarfe A.

Cancer. 2010 Oct 15;116(20):4849-56. doi: 10.1002/cncr.25250.

7.

Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.

Bos AC, van Erning FN, van Gestel YR, Creemers GJ, Punt CJ, van Oijen MG, Lemmens VE.

Eur J Cancer. 2015 Nov;51(17):2553-61. doi: 10.1016/j.ejca.2015.08.016. Epub 2015 Sep 7.

PMID:
26360411
8.

Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.

Hsieh MC, Chiu YW, Velasco C, Wu XC, O'Flarity MB, Chen VW.

J Registry Manag. 2013 Winter;40(4):180-7.

PMID:
24625772
9.

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, McCleary NJ, Meyerhardt JA, Niland J, Kahn KL, Schymura MJ, Schrag D.

J Clin Oncol. 2012 Jul 20;30(21):2624-34. doi: 10.1200/JCO.2011.41.1140. Epub 2012 Jun 4.

10.

Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.

Kim KY, Cha IH, Ahn JB, Kim NK, Rha SY, Chung HC, Roh JK, Shin SJ.

J Surg Oncol. 2013 May;107(6):613-8. doi: 10.1002/jso.23290. Epub 2012 Nov 28.

PMID:
23592499
11.

Completion of therapy by Medicare patients with stage III colon cancer.

Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W.

J Natl Cancer Inst. 2006 May 3;98(9):610-9.

12.

Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer.

Abrams TA, Brightly R, Mao J, Kirkner G, Meyerhardt JA, Schrag D, Fuchs CS.

J Clin Oncol. 2011 Aug 20;29(24):3255-62. doi: 10.1200/JCO.2011.35.0058. Epub 2011 Jul 18. Erratum in: J Clin Oncol. 2012 Jan 20;30(3):343.

13.

Adjuvant therapy for colon cancer.

Aranha O, Benson AB 3rd.

Curr Gastroenterol Rep. 2007 Oct;9(5):415-21. Review.

PMID:
17991344
14.

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.

Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM; Norwegian Gastrointestinal Cancer Group.

Acta Oncol. 2009;48(3):368-76. doi: 10.1080/02841860902755244.

PMID:
19242829
15.

Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.

Kim JY, Kim YJ, Lee KW, Lee JS, Kim DW, Kang SB, Lee HS, Jang NY, Kim JS, Kim JH.

Jpn J Clin Oncol. 2013 Feb;43(2):132-8. doi: 10.1093/jjco/hys195. Epub 2012 Nov 29.

16.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.

Cancer. 2006 Dec 1;107(11):2581-8.

17.

Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.

Wu X, Chen VW, Andrews PA, Chen L, Hsieh M, Fontham ET.

J La State Med Soc. 2004 Sep-Oct;156(5):255-61.

PMID:
15554095
18.

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD.

J Am Geriatr Soc. 2009 Aug;57(8):1403-10. doi: 10.1111/j.1532-5415.2009.02355.x. Epub 2009 Jun 25.

PMID:
19563521
19.

A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.

Phelip JM, Molinié F, Delafosse P, Launoy G, Trétarre B, Bara S, Buémi A, Velten M, Danzon A, Ganry O, Bouvier AM, Grosclaude P, Faivre J.

Gastroenterol Clin Biol. 2010 Feb;34(2):144-9. doi: 10.1016/j.gcb.2009.08.012. Epub 2010 Jan 15.

20.

Treatment and complications in elderly stage III colon cancer patients in the Netherlands.

Hoeben KW, van Steenbergen LN, van de Wouw AJ, Rutten HJ, van Spronsen DJ, Janssen-Heijnen ML.

Ann Oncol. 2013 Apr;24(4):974-9. doi: 10.1093/annonc/mds576. Epub 2012 Nov 7.

Items per page

Supplemental Content

Write to the Help Desk